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Objectives:  To review  and  update  the  evidence  on predictors  of  poor  outcome  (death,  persistent  vegetative  state  or  severe  neurological  disability)  in  adult
comatose  survivors  of  cardiac  arrest,  either  treated  or  not  treated  with  controlled  temperature,  to identify  knowledge  gaps  and to  suggest  a reliable
prognostication  strategy.
Methods:  GRADE-based  systematic  review  followed  by  expert  consensus  achieved  using  Web-based  Delphi  methodology,  conference  calls  and  face-to-face
meetings.  Predictors  based  on clinical  examination,  electrophysiology,  biomarkers  and  imaging  were  included.
Results and  conclusions:  Evidence  from  a  total  of 73  studies  was  reviewed.  The  quality  of evidence  was  low  or very  low  for almost  all  studies.  In  patients  who
are  comatose  with  absent  or  extensor  motor  response  at  ≥72  h  from  arrest,  either  treated  or not  treated  with  controlled  temperature,  bilateral  absence
of either  pupillary  and  corneal  reﬂexes  or  N20  wave  of  short-latency  somatosensory  evoked  potentials  were identiﬁed  as  the  most  robust  predictors.
Early  status  myoclonus,  elevated  values  of neuron  speciﬁc  enolase  at 48–72  h  from  arrest,  unreactive  malignant  EEG  patterns  after  rewarming,  and
presence  of diffuse  signs  of postanoxic  injury  on  either  computed  tomography  or magnetic  resonance  imaging  were  identiﬁed  as  useful but  less  robust
predictors.  Prolonged  observation  and  repeated  assessments  should  be  considered  when  results  of initial  assessment  are  inconclusive.  Although  no  speciﬁc
combination  of predictors  is  sufﬁciently  supported  by available  evidence,  a multimodal  prognostication  approach  is  recommended  in  all  patients.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Severe neurological impairment caused by hypoxic-ischaemic
brain injury is common after resuscitation from cardiac arrest.1
Early identiﬁcation of patients with no chance of a good neurologi-
cal recovery will help to avoid inappropriate treatment and provide
information for relatives.
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simultaneously published in Resuscitation and Intensive Care Medicine [ISSN: 0342-
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In 20062 a landmark review from the Quality Standards
Subcommittee of the American Academy of Neurology (AAN)
recommended a sequential algorithm to predict poor neurological
outcome in comatose survivors within the ﬁrst 72 h after car-
diopulmonary resuscitation (CPR). According to that algorithm,
the presence of myoclonus status epilepticus on day 1, the bilateral
absence of the N20 wave of somatosensory evoked potentials
(SSEPs) or a blood concentration of neuron speciﬁc enolase (NSE)
above 33 mcg  L−1 at days 1–3, and absent pupillary and corneal
reﬂexes or a motor response no better than extension (M1–2)
at day 3 accurately predicted poor outcome. However, the AAN
recommendations need updating:
1. The AAN 2006 review was based on studies conducted before the
advent of therapeutic hypothermia (TH) for post-resuscitation
http://dx.doi.org/10.1016/j.resuscitation.2014.08.011
0300-9572/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/3.0/).
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care. Both TH itself and sedatives or neuromuscular blocking
drugs used to maintain it may  potentially interfere with prognos-
tication indices, especially clinical examination.3 The predictive
value of those indices therefore needs to be re-evaluated in TH-
treated patients.
2. Studies conducted both before4 and after5,6 the AAN 2006 review
showed that the previously recommended thresholds for out-
come prediction using biomarkers were inconsistent.7
3. Evidence for some prognostic tools such as EEG8 and imaging
studies was limited at the time of the 2006 AAN review, and
needs re-evaluation.
4. The AAN 2006 review and previous reviews did not adequately
address some important limitations of prognostication studies,
such as the risk of ‘self-fulﬁlling prophecy’, which is a bias occur-
ring when the treating physicians are not blinded to the results of
the outcome predictor and use it to make a decision to withdraw
life-sustaining treatment (WLST).9
Given the limitations of the current literature and the need for
up-to-date clinical guidance, members of the European Resuscita-
tion Council (ERC) and the Trauma and Emergency Medicine (TEM)
Section of the European Society of Intensive Care Medicine (ESICM)
planned an Advisory Statement on Neurological Prognostication in
comatose survivors of cardiac arrest. The aims of this statement are
to:
1. Update and summarise the available evidence on this topic,
including that on TH-treated patients;
2. Provide practical recommendations on the most reliable prog-
nostication strategies, based on a more robust analysis of the
evidence, in anticipation of the next ERC Guidelines on Resusci-
tation to be published in October 2015;
3. Identify knowledge gaps and suggest directions for future
research.
2. Methods
2.1. Panel selection
The panel for this Advisory Statement included medical spe-
cialists experienced in the management of comatose resuscitated
patients. All the panel members are authors of original studies on
prognostication in post-resuscitation care or have previous expe-
rience in guideline development or systematic evidence review.
Panel members completed a conﬂict of interest declaration, as
recommended.10,11
2.2. Group process
Following an initial conference call and a face-to-face meeting,
the panel members agreed on criteria for study inclusion, grading
methods, and the process timeline. Subsequent consensus on the
evidence and the recommendations was achieved using a Web-
based Delphi method. The document was written using a Web-
based collaborative process and collectively reviewed for content
and wording. A ﬁnal face-to-face meeting was held to ﬁnalise the
statements.
2.3. Inclusion criteria and deﬁnitions
Given the paucity of evidence on neurological prognostication
in children with coma after cardiac arrest, the evidence eval-
uation was restricted to adults. Inclusion criteria are described
in detail elsewhere.12 Brieﬂy, all studies on adult (≥16 years)
patients who were comatose following resuscitation from cardiac
arrest and were treated with TH were considered for inclusion.
Patients deﬁned as unconscious, unresponsive, or having a Glasgow
Coma Scale score (GCS)13 ≤8 were considered as comatose. Stud-
ies including non-comatose patients or patients in hypoxic coma
from causes other than cardiac arrest (e.g., respiratory arrest, car-
bon monoxide intoxication, drowning and hanging) were excluded,
except when a subpopulation of cardiac arrest patients could be
evaluated separately.
Studies were considered for inclusion regardless of both the
cause of arrest and treatment with TH. Pooling of data was strat-
iﬁed according to timing of prognostication and TH treatment.
Poor neurological outcome was  deﬁned as a Cerebral Performance
Category (CPC)14 of 3 to 5 (severe neurological disability, persis-
tent vegetative state or death) as opposed to CPC 1–2 (absent,
mild or moderate neurological disability; see ESM Appendix 1 for
a detailed CPC description). In some studies a CPC 4–5 was  deﬁned
as a poor outcome. When original data were not available to
correct outcome as CPC 3–5, a CPC 4–5 was  accepted as a sur-
rogate poor outcome, assigning the study an indirectness score.
When the outcome was expressed using a modiﬁed Rankin Score
(mRS)15 an equivalent CPC was  calculated based on the equivalence
mRS  ≥4 = CPC ≥ 3.16
2.4. Data source
Results from three recent systematic reviews7,12,17 on post-
arrest prognostication were used as a data source. One of these7
included 50 studies on 2828 patients not treated with TH, the
two other reviews12,17 included a total of 39 studies in 2564 TH-
treated patients. In order to identify further studies published
during the grading and consensus process, the automatic alert sys-
tem of PubMed was  maintained active and the tables of contents
of relevant Journals were screened. This led to inclusion of ﬁve
additional studies.18–22
2.5. Grading
Grading was made according to the Grading of Recom-
mendations Assessment, Development and Evaluation (GRADE)
criteria.23–28 The grading process for included studies is described
in detail in the ESM Appendix 2.
2.5.1. Quality of evidence
According to GRADE, the quality of evidence (QOE) was graded
as high, moderate, low or very low according to the presence of
limitations, indirectness, inconsistency and imprecision. Publica-
tion bias was  not considered, given the difﬁculty of measuring it in
prognostic studies.29
Given the importance of the risk of self-fulﬁlling prophecy, lim-
itations were graded as serious when the treating team was  not
blinded to the results of the predictor of poor outcome that was
being studied, and very serious when the investigated predictor
was used to decide to WLST.
Imprecision was  graded as serious when the upper limit of the
95% conﬁdence intervals (CIs) of the estimate of the false positive
rate (FPR) was  greater than 5%, and very serious when this value
was more than 10%. Conﬁdence intervals were calculated using the
F distribution method, according to Blyth.30
This advisory statement covers the four main categories of prog-
nostic tests: clinical examination, electrophysiology, biomarkers
and imaging. The relevant Evidence Proﬁle tables are included in
the ESM Appendixes 3a–d.
2.5.2. Recommendations
Recommendations in this document are stated as either strong
(‘we recommend’) or weak (‘we suggest’).24,25 The strength of the
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recommendations was based on the following factors25: (1) the
balance between true and false predictions given by that test, i.e.
the test performance as estimated by its sensitivity and speciﬁcity;
(2) the conﬁdence in the magnitude of the estimates (i.e., the quality
of evidence); (3) the resource use, i.e. the cost of the strategy under
evaluation.
3. Clinical examination
3.1. Evidence (ESM table 1)
3.1.1. Ocular reﬂexes
Bilateral absence of pupillary light reﬂex immediately after
recovery of spontaneous circulation (ROSC)31–33 has a very limited
value in predicting poor outcome (FPR is 8 [1–25]). Conversely, at
72 h from ROSC,3,18,33–40 a bilaterally absent pupillary light reﬂex
predicts poor outcome with 0% FPR, both in TH-treated and in non-
TH-treated patients (95% CIs 0–2 and 0–8, respectively); however,
its sensitivity is low (24% and 18% respectively).
A bilaterally absent corneal reﬂex is slightly less speciﬁc than the
pupillary reﬂex for prediction of poor outcome. One reason for this
could be the sensitivity of the corneal reﬂex to interference from
residual effects of sedatives3 or neuromuscular blocking drugs. At
72 h from ROSC, the FPR was 5[0–25]% in one study35 in non-TH-
treated patients and 4[1–7]% in 7 studies3,18,36–40 in TH-treated
patients; sensitivities were 29% and 34% respectively.
3.1.2. Motor response to pain
In non-TH-treated patients35,41 an absent or extensor motor
response to pain, corresponding to a motor score 1 or 2 of the
Glasgow Coma Scale (M ≤ 2) at 72 h from ROSC has a high (74
[68–79]%) sensitivity for prediction of poor outcome, but the FPR is
also high (27[12–48]%). Similar results were observed in TH-treated
patients.3,18,36–40,42–44 Like the corneal reﬂex, the motor response
can be suppressed by the effects of sedatives or neuromuscular
blocking drugs.3
Only a few prognostication studies3,18,21,38,42,44 reported sus-
pension of sedation before clinical examination and no study ruled
out residual effects of neuromuscular blocking drugs using objec-
tive measurements such as median nerve stimulation train-of-four.
No study evaluated the interobserver agreement in clinical exam-
ination. In coma due to multiple causes this agreement is only
moderate (kappa from 0.42 to 0.79).45
While predictors of poor outcome based on clinical examination
are inexpensive and easy to use they cannot be concealed from the
treating team and therefore their results may  potentially inﬂuence
clinical management and cause a self-fulﬁlling prophecy.
3.2. Recommendations
We  recommend:
• Using the bilateral absence of both pupillary and corneal reﬂexes
at 72 h or more from ROSC to predict poor outcome in comatose
survivors from cardiac arrest, either TH-treated or non-TH-
treated.
• Prolonging observation of clinical signs beyond 72 h when inter-
ference from residual sedation or paralysis is suspected, so that
the possibility of obtaining false positive results is minimised.
We  do not suggest using an absent or extensor motor response
to pain (M ≤ 2) alone to predict poor outcome in those patients,
given its high false positive rate. However, due to its high sensi-
tivity, this sign may  be used to identify the population with poor
neurological status needing prognostication or to predict poor
outcome in combination with other more robust predictors.
3.3. Knowledge gaps
• Prospective studies are needed to investigate the pharmacoki-
netics of sedative drugs and neuromuscular blocking drugs in
post-cardiac arrest patients, especially those treated with con-
trolled temperature.
• Clinical studies are needed to evaluate the reproducibility of
clinical signs used to predict outcome in comatose post-arrest
patients. In particular, clinical examination tends to underesti-
mate the presence of pupillary reﬂex, which can be detected and
quantiﬁed using pupillometry.46,47
4. Myoclonus and status myoclonus
4.1. Evidence (ESM table 1)
Myoclonus is a clinical phenomenon consisting of sudden, brief,
involuntary jerks caused by muscular contractions or inhibitions.
A prolonged period of continuous and generalised myoclonic jerks
is commonly described as status myoclonus. There is no deﬁni-
tive consensus on the duration or frequency of myoclonic jerks
required to qualify as status myoclonus, however in prognostica-
tion studies in comatose survivors of cardiac arrest the minimum
reported duration is 30 min. The names and deﬁnitions used for
status myoclonus vary among those studies (see ESM Appendix 4).
Terms like status myoclonus, myoclonic status, generalised sta-
tus myoclonicus, and myoclonus (or myoclonic) status epilepticus
have been used interchangeably. Although the term myoclonic
status epilepticus may  suggest an epileptiform nature for this phe-
nomenon, in post-anoxic comatose patients clinical myoclonus
is only inconsistently associated with epileptiform activity on
EEG.48,49
In comatose survivors of cardiac arrest treated with
TH,21,42,44,48,50,51 the presence of myoclonic jerks (not status
myoclonus) within 72 h from ROSC is not consistently associated
with poor outcome (FPR 5[3–8]%; sensitivity 33%). In one study,36
presence of myoclonic jerks within 7 days from ROSC was com-
patible with neurological recovery (FPR 113–26%; sensitivity 54%).
A status myoclonus starting within 48 h from ROSC was
consistently associated with a poor outcome (FPR 0 [0–4]%; sen-
sitivity 15%) in prognostication studies made in non-TH-treated
patients,35,52,53 and is also highly predictive (FPR 0.5% [0–3]; sen-
sitivity 16%) in TH-treated patients.3,48,54 However, several case
reports of good neurological recovery despite an early-onset, pro-
longed and generalised myoclonus have been published. In some
of these cases,55–60 myoclonus persisted after awakening and
evolved into a chronic action myoclonus (Lance-Adams syndrome).
In others61,62 it disappeared with recovery of consciousness. The
exact time when recovery of consciousness occurred in these cases
may have been masked by the myoclonus itself and by ongoing
sedation.
4.2. Recommendations
We suggest:
• Using the term status myoclonus52 to indicate a continuous and
generalised myoclonus persisting for ≥30 min  in comatose sur-
vivors of cardiac arrest
• Using the presence of a status myoclonus within 48 h from ROSC
in combination with other predictors to predict poor outcome
in comatose survivors of cardiac arrest, either TH-treated or
non-TH-treated
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• Evaluating patients with post-arrest status myoclonus off seda-
tion whenever possible; in those patients, EEG recording can be
useful to identify EEG signs of awareness and reactivity61 and to
reveal a coexistent epileptiform activity.
4.3. Knowledge gaps
• A consensus-based, uniform nomenclature and deﬁnition for sta-
tus myoclonus is needed.
• The distinctive pathophysiological and electrophysiological fea-
tures of postanoxic status myoclonus, in comparison with more
benign forms of myoclonus, like the Lance-Adams syndrome,
need to be further investigated.
5. Bilateral absence of SSEP N20 wave
5.1. Evidence (ESM table 2)
In non-TH-treated post-arrest comatose patients, bilateral
absence of the N20 wave of short-latency somatosensory evoked
potentials (SSEPs) predicts death or vegetative state (CPC 4–5) with
0[0–5]% FPR as early as 24 h from ROSC,35,63,64 and it remains
predictive during the following 48 h with a consistent sensitivity
(45–46%).4,35,63,65,66 Among a total of 287 patients with no N20 SSEP
wave at ≤72 h from ROSC, there was only one false positive result67
(positive predictive value 99.7[98–100]%).
In TH-treated patients, a bilaterally absent N20 wave accurately
predicts poor outcome both during TH (FPR 0[0–2]%) and after
rewarming (at 72 h from ROSC) (FPR 0.4[0–2]%), even if two  isolated
cases of false positive prediction have been reported.68,69 In the
largest observational study on SSEP in TH-treated patients,38 three
patients with a bilaterally absent N20 during TH rapidly recov-
ered consciousness after rewarming and ultimately had a good
outcome. In a post-hoc assessment, two experienced neurophysiol-
ogists reviewed blindly the original tracings and concluded that the
SSEP recordings were undeterminable because of excessive noise.
Correction of the results after this reassessment led to a FPR of
0[0–3]%.
Interobserver agreement for SSEPs in anoxic-ischaemic coma is
moderate to good but is inﬂuenced by noise.70,71
In most prognostication studies, absence of the N20 wave after
rewarming has been used–alone or in combination–as a crite-
rion for deciding on WLST, with a consequent risk of self-fulﬁlling
prophecy (see ESM Appendix 3b).  SSEP results are more likely to
inﬂuence physicians’ and families’ WLST decisions than those of
clinical examination or EEG.72
5.2. Recommendations
We  recommend:
• Using bilateral absence of N20 SSEP wave at ≥72 h from ROSC to
predict poor outcome in comatose survivors from cardiac arrest
treated with controlled temperature.
We suggest:
• Using SSEP at ≥24 h after ROSC to predict poor outcome in
comatose survivors from cardiac arrest not treated with con-
trolled temperature.
SSEP recording requires appropriate skills and experience, and
utmost care should be taken to avoid electrical interference from
muscle artefacts or from the ICU environment.
5.3. Knowledge gaps
• Most of prognostic accuracy studies on SSEPs in post-anoxic coma
were not blinded, which may  have led to an overestimation of the
SSEP prognostic accuracy due to a self-fulﬁlling prophecy. Blinded
studies will be needed to assess the relevance of this bias.
6. Electroencephalogram (EEG)
6.1. Evidence (ESM table 2)
6.1.1. Absence of EEG reactivity
In TH-treated patients, absence of EEG background reactivity
during TH is almost invariably associated with poor outcome (FPR
2 [1–7]%;21,44,50) while after rewarming at 48–72 h from ROSC it
predicts a poor outcome with 0 [0–3]% FPR.42,44,50 However, in
one study in posthypoxic myoclonus48 three patients with no EEG
reactivity after rewarming from TH had a good outcome. Among
four prognostication studies on absent EEG reactivity after cardiac
arrest included in this document, three21,42,44 were made by the
same group of investigators. Limitations of EEG reactivity include
being operator dependent and non-quantitative, and lacking stan-
dardisation. Techniques for automated analysis of EEG background
reactivity are under investigation.73
6.1.2. Status epilepticus
In TH-treated patients, the presence of status epilepticus (SE),
i.e., a prolonged epileptiform activity, during TH or immediately
after rewarming51,54,74 is almost invariably followed by poor out-
come (FPR from 0% to 6%). Among those patients, absence of EEG
reactivity51,75 or a discontinuous EEG background76 predicted no
chance of neurological recovery. All studies on SE included only
a few patients. Deﬁnitions of SE were inconsistent among those
studies (see ESM Appendix 5).
6.1.3. Low voltage EEG
According to recent guidelines,77 the voltage of background EEG
is deﬁned as low when most or all activity is <20 V (measured
from peak to trough) in longitudinal bipolar with standard 10–20
electrodes, while suppression is deﬁned as all voltage being <10 V.
In two  studies35,67 in non-TH-treated patients, a low-voltage
EEG (≤20–21 V) at 1-3 days after ROSC predicted poor outcome
with 0[0–6]% FPR. In one of these studies,35 however, the presence
of this EEG pattern was  used as a criterion for WLST.
In two  studies76,78 in TH-treated patients a ﬂat or low-voltage
tracing on continuous EEG recorded during TH or immediately after
rewarming was inconsistently associated to a poor outcome (FPR
from 0% to 6%). In two studies79,80 a bispectral index (BIS) value
of 6 or less recorded during TH, corresponding to a ﬂat or low-
amplitude EEG, predicted poor outcome with 0% [0–6] FPR, while
higher BIS values were less speciﬁc.81 However, in a subsequent
study82 a BIS≤6 was  not 100% reliable (FPR 17%7–32). There is lim-
ited evidence76,82 on the predictive value of low EEG voltage after
rewarming from TH.
Amplitude of the EEG signal may  depend on the effect of drugs,
body temperature, and on a variety of technical conditions such as
skin and scalp impedance, inter-electrode distances, size, type and
placement of the exploring electrodes, and type of ﬁlters adopted,
as well as patient-speciﬁc issues.83
6.1.4. Burst-suppression
According to a recent deﬁnition,77 burst-suppression is deﬁned
as more than 50% of the EEG record consisting of periods of EEG
voltage <10 V, with alternating bursts. In comatose survivors
of cardiac arrest, either TH-treated or non-TH-treated, burst-
suppression is usually a transient ﬁnding. During the ﬁrst 24–48 h
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after ROSC67 in non-TH-treated patients or during TH44,78,84 burst-
suppression is common and it may  be compatible with neurological
recovery while at ≥72 h from ROSC35,76,85 a persisting burst-
suppression pattern is less common, but is consistently associated
with poor outcome. In one case61 a good recovery was reported
despite an EEG burst-suppression pattern recorded at 72 h from
ROSC; in that case, EEG reactivity was maintained. Deﬁnitions of
burst-suppression were inconsistent among prognostication stud-
ies (see ESM Appendix 6).
6.2. Recommendations
We  suggest:
• Using EEG-based predictors such as absence of EEG reactivity to
external stimuli, presence of burst-suppression or status epilep-
ticus at ≥72 h after ROSC to predict poor outcome in comatose
survivors from cardiac arrest.
• Using these predictors only in combination (i.e. presence of burst-
suppression or status epilepticus plus an unreactive background)
and combining them with other predictors, since these criteria
lack standardisation and the relevant evidence is limited to a few
studies performed by experienced electrophysiologists
• Not using a low EEG voltage to predict outcome in comatose
survivors of cardiac arrest, because of the limited evidence and
the risk of interference from hypothermia, ongoing sedation and
technical factors.
We  recommend not using burst-suppression for prognostica-
tion during the ﬁrst 24–36 h after ROSC or during TH in comatose
survivors of cardiac arrest.
Apart from its prognostic signiﬁcance, recording of EEG—either
continuous or intermittent—in comatose survivors of cardiac arrest
both during TH and after rewarming is helpful to assess the level
of consciousness—which may  be masked by prolonged sedation,
neuromuscular dysfunction or myoclonus—and to detect and treat
non-convulsive seizures8 which may  occur in about one quarter of
comatose survivors of cardiac arrest.54,76,86
6.3. Knowledge gaps
• Larger prospective studies on the prevalence and the predictive
value of EEG changes in comatose survivors of cardiac arrest are
needed, especially in patients who have been rewarmed from
controlled temperature.
• The deﬁnition of SE and the modalities for eliciting and evaluating
EEG reactivity need standardisation. In future studies, deﬁnitions
of burst suppression and low-voltage EEG should comply with
recent recommendations.77
• It is not clear whether postanoxic SE is only a marker of brain
injury or whether it contributes directly to neurological injury,
nor if antiepileptic treatments may  potentially improve its out-
come.
7. Biomarkers
NSE and S-100B are protein biomarkers that are released fol-
lowing injury to neurons and glial cells, respectively. Blood values
of NSE or S-100B after cardiac arrest are likely to correlate with the
extent of anoxic-ischaemic neurological injury from cardiac arrest
and, therefore, with the severity of neurological outcome.
Advantages of biomarkers over both EEG and clinical examina-
tion include quantitative results and likely independence from the
effects of sedatives. Their main limitation as prognosticators is that
it is difﬁcult to ﬁnd a consistent threshold for identifying patients
destined to a poor outcome with a high degree of certainty. In fact,
serum concentrations of biomarkers are per se continuous vari-
ables, which limits their applicability for predicting a dichotomous
outcome, especially when a threshold for 0% FPR is required.
7.1. Evidence (ESM table 3)
7.1.1. Neuron-speciﬁc enolase (NSE)
In non-TH-treated patients the 2006 AAN review2 identiﬁed an
NSE threshold of 33 mcg L−1 at days 1 to 3 from ROSC as an accu-
rate predictor of poor outcome with 0% FPR. However, in a study4
included in that review this threshold was 47.6 mcg  L−1 at 24 h,
while in a large cohort study5 published after the AAN review,
this threshold was  65.0 mcg  L−1 at 48 h and 80 mcg  L−1 at 72 h. In
three other studies,3,63,87 values of NSE between 65 mcg  L−1 and
85 mcg  L−1 at 3-5 days were reported as compatible with recovery
of consciousness.
In TH-treated patients the threshold for 0% FPR varied
between 38.1 mcg  L−1 and 80.8 mcg  L−1 at 24 h,20,74,88–90 between
25 mcg  L−1 and 151.5 mcg  L−1 at 48 h,20,22,38,74,88–93 and between
27.3 mcg  L−1 and 78.9 mcg  L−1 at 72 h.6,90,91 However, the distribu-
tion of NSE values in available studies5,6,22,38,88,91 indicates that NSE
values above 60 mcg  L−1 at 48–72 h from ROSC are very rarely asso-
ciated with good outcome. Limited evidence20,89,94 suggests that
the discriminative value of NSE levels at 48–72 h is higher than at
24 h.
7.1.2. S-100B
S-100B is less well documented than is NSE. As for NSE, inconsis-
tencies were found in its thresholds for 0% FPR. In non-TH-treated
patients, these thresholds ranged from 0.19 to 5.2 mcg  L−1 at
24 h4,92,95 and from 0.12 to 0.25 mcg  L−1 at 48 h.92,96,97 Precision
was very low in all studies.
In TH-treated patients, the thresholds for a 0% FPR ranged from
0.18 to 1.15 mcg  L−1 at 24 h after ROSC,90,92,98 and from 0.30 to
2.15 mcg  L−1 at 48 h.82,90 Finally, in one study90 the threshold for
0% FPR at 72 h was 0.92 mcg  L−1.
The main reasons for the observed variability in biomarker
thresholds may  include the use of heterogeneous measure-
ment techniques,99,100 the presence of extra-neuronal sources of
biomarkers (haemolysis and neuroendocrine tumours for NSE,101
muscle and adipose tissue breakdown for S-100B102), and the
incomplete knowledge of the kinetics of their blood concentra-
tions in the ﬁrst few days after ROSC. Some evidence89,90,94 suggests
that not only the biomarkers’ absolute concentrations but also their
trends over time may  have predictive value.
7.2. Recommendations
We suggest:
• Using high serum values of NSE at 48–72 h from ROSC in combina-
tion with other predictors for prognosticating a poor neurological
outcome in comatose survivors from cardiac arrest, either TH-
treated or non-TH-treated. However, no threshold enabling
prediction with zero FPR can be recommended.
• Using utmost care and preferably sampling at multiple time-
points when assessing NSE to avoid false positive results due to
haemolysis.
7.3. Knowledge gaps
• There is a need for standardisation of the measuring techniques
for NSE and S-100 in cardiac arrest patients.
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• Little information is available on the kinetics of the blood concen-
trations of biomarkers in the ﬁrst few days after cardiac arrest.
8. Imaging
8.1. Evidence (ESM table 4)
8.1.1. Brain CT
Brain CT is often performed in resuscitated comatose patients,
mainly to exclude further causes of coma, as subarachnoid
haemorrhage.103 The main CT ﬁnding of global anoxic-ischaemic
cerebral insult following cardiac arrest is cerebral oedema,104
which appears as a reduction in the depth of cerebral sulci (sulcal
effacement) and an attenuation of the grey matter/white mat-
ter (GM/WM)  interface, due to a decreased density of the GM.  In
one study,105 the presence of this pattern on brain CT performed
immediately after resuscitation predicted poor outcome with 81%
sensitivity and 8% [0–38] FPR. The attenuation of the GM/WM  inter-
face has been quantitatively measured as the ratio (GWR) between
the GM and the WM densities. The GWR  threshold below which
poor outcome was predicted with 0% FPR ranged between 1.12 and
1.22.20,33,106 The methods for GWR  calculation were inconsistent
among studies.
8.1.2. MRI
Advantages of MRI  over brain CT include a better spatial deﬁ-
nition and a high sensitivity for identifying ischaemic brain injury;
however, its use can be problematic in the most clinically unstable
patients.107
The earliest post-ischaemic MRI  change is hyperintensity in cor-
tical areas or basal ganglia on diffusion weighted imaging (DWI)
sequences. In two small studies,108,109 the presence of large mul-
tilobar changes on DWI  or FLAIR MRI  sequences performed within
ﬁve days from ROSC was consistently associated with death or veg-
etative state while focal or small volume lesions were not.93 In
patients with poor outcome after resuscitation from cardiac arrest,
MRI  can reveal extensive changes when results of other predictors
such as SSEP or ocular reﬂexes are normal.93,107
Apparent diffusion coefﬁcient (ADC) is a quantitative mea-
sure of ischaemic DWI  changes. ADC values between 700 and
800 × 10−6 mm2/s are considered to be normal.107 Several meth-
ods have been used to quantify the DWI  changes following cardiac
arrest in order to predict outcome. Measured parameters include
whole-brain ADC,110 the proportion of brain volume with low
ADC111 and the lowest ADC value in speciﬁc brain areas, such as the
cortical occipital area and the putamen.88,112 The ADC thresholds
associated with 0% FPR vary among studies. These methods depend
partly on subjective human decision in identifying the region of
interest to be studied and in the interpretation of results, although
automated analysis has recently been proposed.19 According to one
study,109 the optimal time window for prognostication based on
ADC is 3–5 days from ROSC in the cortical structures and 6–8 days
in the subcortical structures. Both the timing and severity of MRI
changes after arrest differ between cortical areas.
Advanced MRI  techniques, such as fractional anisotropy113 and
axial diffusivity in diffusion-tensor (DT) imaging114 have recently
been tested in humans to evaluate the white matter disorgani-
sation and the axonal damage following diffuse anoxic-ischemic
brain injury, respectively. Limited evidence shows these techniques
may  be useful to predict outcome in patients who are persistently
comatose after cardiac arrest and that their accuracy is comparable
or superior to that of ADC.113
All studies on prognostication after cardiac arrest using imag-
ing have a small sample size with a consequent low precision,
and a very low quality of evidence. Most of those studies are
retrospective, and brain CT or MRI  had been made at discretion
of the treating physician, which may  have caused a selection bias
and overestimated their performance.
8.2. Recommendations
We  suggest:
• Using the presence of a marked reduction of the GM/WM  ratio
or sulcal effacement on brain CT within 24 h after ROSC or the
presence of extensive reduction in diffusion on brain MRI  at 2-5
days after ROSC to predict a poor outcome in patients who are
comatose after resuscitation from cardiac arrest both TH-treated
or non-TH-treated
• Using brain CT and MRI  for prognosticating poor outcome after
cardiac arrest only in combination with other predictors.
• Using brain imaging studies for prognostication only in centres
where speciﬁc experience is available, given the limited num-
ber of studied patients, the spatial and temporal variability of
post-anoxic changes in both CT and MRI, and the lack of stan-
dardisation for quantitative measures of these changes.
8.3. Knowledge gaps
• Evidence on imaging studies in comatose survivors of cardiac
arrest is limited by small sample size and likely selection bias.
Larger prospective studies are needed to conﬁrm the results of
the currently available studies.
• The severity of brain CT and MRI  changes after global ischaemic
injury will need a standardised description, e.g. using scoring
systems similar to those used for traumatic brain injury.115
• The prognostic value of quantitative vector indices derived from
DT imaging, such as fractional anisotropy and axial diffusivity
need to be evaluated in future studies.
9. Self-fulﬁlling prophecy
Almost all prognostication studies reviewed in this document
were assigned a low or very low quality of evidence (see Evidence
Proﬁle Tables on ESM Appendix 3a–d) the main reason being the risk
of self-fulﬁlling prophecy. In fact, only 9/73 studies (12%)—three of
which are from the same group—reported blinding of the treat-
ing team from the results of the predictor under investigation. In
two of these studies37,38 results of the predictor (absence of N20
SSEP wave) recorded during TH were not disclosed, but if patients
remained comatose after rewarming, a second SSEP was performed
and results were disclosed to the treating team, who  used this infor-
mation for treatment decisions. A treatment suspension policy was
reported in 37/73 studies (51%), although only 27 of those studies
described the criteria for WLST. In 14/37 studies (38%) the treat-
ment suspension policy was based, at least in part, on one or more
of the predictors under investigation (see ESM Table 5). Treatment
limitations were applied at a minimum of 3 days or less from cardiac
arrest in 12 studies and from 3 to 7 days in 9 studies, while in the
remaining studies the minimal duration of life support measures
was not reported.
Prevention of self-fulﬁlling prophecy bias would require blind-
ing of test results to the treating team and providing sufﬁciently
prolonged life support in patients who  do not recover conscious-
ness after resuscitation and rewarming. Both those tasks are
difﬁcult to accomplish. Some predictors, such as results of clini-
cal examination, cannot be concealed to the treating team. Others,
such as EEG, should not be concealed as they can reveal the pres-
ence of potentially treatable complications, like seizures. In some
institutions, having a dedicated investigator not involved in patient
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Fig. 1. Suggested prognostication algorithm. The algorithm is entered ≥72 h after ROSC if, after the exclusion of confounders (particularly residual sedation), the patient
remains unconscious with a Glasgow Motor Score of 1 or 2. The absence of pupillary and corneal reﬂexes, and/or bilaterally absent N20 SSEP wave indicates a poor outcome
is  very likely. If neither of the features is present, wait at least 24 h before reassessing. At this stage two or more of the following indicate that a poor outcome is likely: status
myoclonus ≤48 h; high neuron speciﬁc enolase values; unreactive EEG with burst suppression or status epilepticus; diffuse anoxic injury on brain CT and/or MRI. If none of
these  criteria are met  consider continue to observe and re-evaluate.
management who will ensure blinding of collected data may  not be
feasible.80 On the other hand, indeﬁnite supportive care in poten-
tially hopeless patients raises both ethical and ﬁnancial concerns.
Even when the risk of self-fulﬁlling prophecy cannot be avoided,
however, in order to adequately account for this bias it is desirable
that future prognostic accuracy studies report in detail the crite-
ria for withdrawal or limitation of life-sustaining treatment, as has
been done in recent trials.116
10. Practical approach: suggested prognostication strategy
Prognostication is indicated in patients with prolonged coma
after resuscitation. A thorough clinical examination should be
performed daily to detect signs of neurological recovery such as
purposeful movements or to identify a clinical picture suggesting
that brain death has occurred.
Following global post-anoxic injury, the brain will make a
gradual recovery. Brainstem reﬂexes return ﬁrst, then the motor
response to pain and, ﬁnally, cortical activity and consciousness.117
This process is completed within 72 h from arrest.53,117 Conse-
quently, in absence of residual sedation, 72 h after ROSC seems to be
a suitable time for prognostication. However, in patients who have
received sedatives ≤12 h before the 72 h neurological assessment,
the reliability of clinical examination may  be reduced.3 Special
care must be taken in TH-treated patients, since hypothermia pro-
longs the effects of both opiates118 and neuromuscular blocking
drugs.119,120
Before decisive assessment is performed, major confounders
must be excluded;121,122 apart from sedation and neuromuscu-
lar blockade, these include hypothermia, severe hypotension,
hypoglycaemia, and metabolic and respiratory derangements.
Sedatives and neuromuscular blocking drugs should be suspended
long enough to avoid interference with clinical examination.
Short-acting drugs are preferred whenever possible. When resid-
ual sedation/paralysis is suspected, consider using antidotes to
reverse the effects of these drugs. Be careful if using ﬂumazenil to
reverse the effects of benzodiazepines, since this drug may  lower
the seizure threshold.
We suggest using the prognostication strategy outlined in the
algorithm on Fig. 1 in all comatose patients with an absent or exten-
sor motor response to pain at ≥72 h from ROSC. Results of earlier
prognostic tests should also be considered at this time point.
Evaluate the most robust predictors ﬁrst. These predictors have
the highest speciﬁcity and precision (FPR <5% with 95%CIs <5%
in patients treated with controlled temperature) and have been
documented in >5 studies from at least three different groups
of investigators. They include bilaterally absent pupillary reﬂexes
at ≥72 h from ROSC and bilaterally absent SSEP N20 wave after
rewarming (this last sign can be evaluated at ≥24 h from ROSC
in patients who have not been treated with controlled tempera-
ture). Based on exert opinion, we suggest combining the absence
of pupillary reﬂexes with those of corneal reﬂexes for predicting
poor outcome at this time point. Both these predictors maintain
their predictive value irrespective of hypothermia treatment.18
If none of the signs above is present, a group of less accurate
predictors can be evaluated, but the degree of conﬁdence in their
prediction will be lower. These have FPR <5% but wider 95% CIs
than the previous predictors, and/or their deﬁnition/threshold is
inconsistent in prognostication studies. These predictors include
the presence of early status myoclonus (within 48 h from ROSC),
high values of serum NSE at 48 h-72 h after ROSC, an unreactive
malignant EEG pattern (burst-suppression, status epilepticus) after
rewarming, the presence of a marked reduction of the GM/WM  ratio
or sulcal effacement on brain CT within 24 h after ROSC or the pres-
ence of diffuse ischemic changes on brain MRI  at 2–5 days after
ROSC. Based on expert opinion, we suggest waiting at least 24 h
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after the ﬁrst prognostication assessment and conﬁrming uncon-
sciousness with M1-2 before using this second set of predictors.
We also suggest combining at least two of these predictors for
prognostication.
No speciﬁc NSE threshold for prediction of poor outcome with
0% FPR can be recommended at present, although in all the studies
we analysed NSE values greater than 60 mcg  L−1 at 48–72 h were
very rarely associated with a false positive prediction. Ideally, every
laboratory hospital assessing NSE should create its own normal val-
ues and cut-off levels based on the test kit used. Care should be
taken to avoid haemolysis when sampling NSE.
Although the most robust predictors showed no false positives
in most studies, none of them singularly predicts poor outcome
with absolute certainty when the relevant comprehensive evidence
is considered. Moreover, those predictors have often been used for
WLST decisions, with the risk of a self-fulﬁlling prophecy. For this
reason, we recommend that prognostication should be multimodal
whenever possible, even in presence of one of these predictors.
Apart from increasing safety, limited evidence20,21,42,82 also sug-
gests that multimodal prognostication increases sensitivity.
When prolonged sedation and/or paralysis is necessary, for
example, because of the need to treat severe respiratory insufﬁ-
ciency, we recommend postponing prognostication until a reliable
clinical examination can be performed. Biomarkers, SSEP and imag-
ing studies may  play a role in this context, since they are insensitive
to drug interference.
When dealing with an uncertain outcome, clinicians should con-
sider prolonged observation. Absence of clinical improvement over
time suggests a worse outcome. Although awakening has been
described as late as 25 days after arrest,54,61,123 most survivors
will recover consciousness within one week.93,124–126 In a recent
observational study,126 94% of patients awoke within 4.5 days from
rewarming and the remaining 6% awoke within ten days.
11. Conclusions
A careful clinical neurological examination remains the foun-
dation for prognostication of the comatose patient after cardiac
arrest.127 Adequate time should be given initially for the early
awakeners to regain consciousness and to avoid interference from
residual effects of sedatives and/or neuromuscular blocking drugs.
This implies waiting until 72 h or more after ROSC before predicting
poor outcome, although some indicators can be evaluated ear-
lier. Whenever possible, prognosticate using multiple predictors,
depending on locally available tests and expertise. If the results
of prognostic tests produce conﬂicting results or prognostication
is uncertain, we  recommend further clinical observation and re-
evaluation.
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